Literature DB >> 18227595

Community-based study on seroprevalence of herpes simplex virus type 2 infection in New Delhi.

R Chawla1, P Bhalla, K Bhalla, M Meghachandra Singh, S Garg.   

Abstract

PURPOSE: To determine the seroprevalence of herpes simplex virus type 2 (HSV-2) in two urban communities in Delhi and to correlate the presence of HSV-2 seroprevalence with sociodemographic profile, risk factors and presence of other reproductive tract infections (RTIs).
METHODS: Men and women aged between 15-49 years from an urban slum and an urban middle class colony were invited to participate in the study. They provided interview information; blood for HSV-2, HIV and syphilis serology; first void urine specimens for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis infection; and genital specimens for diagnosis of bacterial vaginosis, vaginal candidiasis and trichomoniasis.
RESULTS: The prevalence of HSV-2 seropositivity was found to be 7 and 8.6% in men and women, respectively. HSV-2 seropositivity was found to be significantly associated with urban middle class community and older age. No statistically significant correlation was found between HSV-2 seropositivity and other laboratory-confirmed RTIs.
CONCLUSIONS: The findings of our study indicate a relatively low prevalence of HSV-2 seropositivity and other sexually transmitted infections in the two communities that were studied.

Entities:  

Mesh:

Year:  2008        PMID: 18227595     DOI: 10.4103/0255-0857.38855

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  2 in total

1.  Herpes simplex virus type 2: Seroprevalence in antenatal women.

Authors:  Shagufta Rathore; Aditi Jamwal; Vipin Gupta
Journal:  Indian J Sex Transm Dis AIDS       Date:  2010-01

2.  Seroprevalence and risk factors of herpes simplex virus type-2 infection among pregnant women in Northeast India.

Authors:  Dipankar Biswas; Biswajyoti Borkakoty; Jagadish Mahanta; Kamini Walia; Lahari Saikia; Brogen S Akoijam; Lobsang Jampa; Alia Kharkongar; Eric Zomawia
Journal:  BMC Infect Dis       Date:  2011-11-23       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.